OpenURL Connection Search

Select item for more details and to access through your institution.

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Published in:
Familial Cancer, 2015, v. 14, n. 3, p. 355, doi. 10.1007/s10689-015-9788-x
By:
- Wevers, M.;
- Schmidt, M.;
- Engelhardt, E.;
- Verhoef, S.;
- Hooning, M.;
- Kriege, M.;
- Seynaeve, C.;
- Collée, M.;
- Asperen, C.;
- Tollenaar, R.;
- Koppert, L.;
- Witkamp, A.;
- Rutgers, E.;
- Aaronson, N.;
- Rookus, M.;
- Ausems, M.
Publication type:
Article
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
Published in:
British Journal of Cancer, 2007, v. 96, n. 9, p. 1335, doi. 10.1038/sj.bjc.6603725
By:
- Hermsen, B. B. J.;
- Olivier, R. I.;
- Verheijen, R. H. M.;
- van Beurden, M.;
- de Hullu, J. A.;
- Massuger, L. F.;
- Burger, C. W.;
- Brekelmans, C. T.;
- Mourits, M. J.;
- de Bock, G. H.;
- Gaarenstroom, K. N.;
- van Boven, H. H.;
- Mooij, T. M.;
- Rookus, M. A.
Publication type:
Article
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
Published in:
2005
By:
- van Sprundel, T. C.;
- Schmidt, M. K.;
- Rookus, M. A.;
- Brohet, R.;
- van Asperen, C. J.;
- Rutgers, E. J. Th.;
- van't Veer, L. J.;
- Tollenaar, R. A. E. M.
Publication type:
journal article
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
Published in:
British Journal of Cancer, 2004, v. 90, n. 8, p. 1492, doi. 10.1038/sj.bjc.6601692
By:
- Olivier, R. I.;
- Lubsen, M. A. C.;
- Rookus, M. A.;
- Mooij, T. M.;
- van de Vijver, M. J.;
- Veer, L. J. van't;
- van Beurden, M.
Publication type:
Article
Response.
Published in:
2015
By:
- Heemskerk-Gerritsen, B. A. M.;
- Hooning, M. J.;
- Rookus, M. A.;
- all authors
Publication type:
commentary
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv033
By:
- Heemskerk-Gerritsen, B. A. M.;
- Seynaeve, C.;
- van Asperen, C. J.;
- Ausems, M. G. E. M.;
- Collée, J. M.;
- van Doorn, H. C.;
- Gomez Garcia, E. B.;
- Kets, C. M.;
- van Leeuwen, F. E.;
- Meijers-Heijboer, H. E. J.;
- Mourits, M. J. E.;
- van Os, T. A. M.;
- Vasen, H. F. A.;
- Verhoef, S.;
- Rookus, M. A.;
- Hooning, M. J.
Publication type:
Article
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
Published in:
2015
By:
- Heemskerk-Gerritsen, B A M;
- Seynaeve, C;
- van Asperen, C J;
- Ausems, M G E M;
- Collée, J M;
- van Doorn, H C;
- Gomez Garcia, E B;
- Kets, C M;
- van Leeuwen, F E;
- Meijers-Heijboer, H E J;
- Mourits, M J E;
- van Os, T A M;
- Vasen, H F A;
- Verhoef, S;
- Rookus, M A;
- Hooning, M J;
- Hereditary Breast and Ovarian Cancer Research Group Netherlands
Publication type:
Journal Article

Found: 7

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Response.

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.